A decision made last month by the Centers for Medicare & Medicaid Services (CMS; Baltimore, Maryland) means another 90,000 patients a year will qualify for reimbursement coverage to receive implantable cardioverter defibrillators (ICDs), but the coverage guidelines fall short for another 200,000 people researchers say would benefit from the devices.